They concluded that the most auspicious biomarkers for CCA are the EV-containing Ras-related GTP binding D (RRAGD), MAP6-domain-containing 1 (MAP6D1), and INO80 complex subunit D (INO80D) [106]. This evidence concerns the gene RRAGD and cholangiocarcinoma.